References:

Birketvedt, GS, M Shimshi, T Erling, and J Florholmen. “Experiences with Three Different Fiber Supplements in Weight Reduction.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 11, no. 1 (January 1, 2005): PI5-8. [PubMed]
Cairella, M, and G Marchini. “[Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].” La Clinica terapeutica 146, no. 4 (April 1, 1995): 269–74. [PubMed]
Doi, K. “Effect of Konjac Fibre (Glucomannan) on Glucose and Lipids.” European Journal of Clinical Nutrition 49 Suppl 3 (October 1, 1995): S190-7. [PubMed]
Henry, DA, AS Mitchell, J Aylward, MT Fung, J McEwen, and A Rohan. “Glucomannan and Risk of Oesophageal Obstruction.” British Medical Journal (Clinical Research Ed.) 292, no. 6520 (March 1, 1986): 591–92. [PubMed]
Keithley, Joyce K., Barbara Swanson, Susan L. Mikolaitis, Mark DeMeo, Janice M. Zeller, Lou Fogg, and Jehan Adamji. “Safety and Efficacy of Glucomannan for Weight Loss in Overweight and Moderately Obese Adults.” Journal of Obesity 2013 (2013): 1–7. https://doi.org/10.1155/2013/610908.
Livieri, C, F Novazi, and R Lorini. “[The use of highly purified glucomannan-based fibers in childhood obesity].” La Pediatria medica e chirurgica : Medical and surgical pediatrics 14, no. 2 (March 1, 1992): 195–98. [PubMed]
Salas-Salvadó, J, X Farrés, X Luque, S Narejos, M Borrell, J Basora, A Anguera, et al. “Effect of Two Doses of a Mixture of Soluble Fibres on Body Weight and Metabolic Variables in Overweight or Obese Patients: A Randomised Trial.” The British Journal of Nutrition 99, no. 6 (June 1, 2008): 1380–87. [PubMed]
Vasques, CA, S Rossetto, G Halmenschlager, R Linden, E Heckler, MS Fernandez, and JL Alonso. “Evaluation of the Pharmacotherapeutic Efficacy of Garcinia Cambogia plus Amorphophallus Konjac for the Treatment of Obesity.” Phytotherapy Research : PTR 22, no. 9 (September 1, 2008): 1135–40. [PubMed]
Vido, L, P Facchin, I Antonello, D Gobber, and F Rigon. “Childhood Obesity Treatment: Double Blinded Trial on Dietary Fibres (Glucomannan) versus Placebo.” Padiatrie Und Padologie 28, no. 5 (January 1, 1993): 133–36. [PubMed]
Villaverde, AF, S Benlloch, M Berenguer, Rayón Miguel, R Pina, and J Berenguer. “Acute Hepatitis of Cholestatic Type Possibly Associated with the Use of Glucomannan (Amorphophalus Konjac).” Journal of Hepatology 41, no. 6 (December 1, 2004): 1061–62. [PubMed]
Vita, PM, A Restelli, P Caspani, and R Klinger. “[Chronic use of glucomannan in the dietary treatment of severe obesity].” Minerva medica 83, no. 3 (March 1, 1992): 135–39. [PubMed]
Walsh, DE, V Yaghoubian, and A Behforooz. “Effect of Glucomannan on Obese Patients: A Clinical Study.” International Journal of Obesity 8, no. 4 (January 1, 1984): 289–93. [PubMed]
Wood, RJ, ML Fernandez, MJ Sharman, R Silvestre, CM Greene, TL Zern, S Shrestha, et al. “Effects of a Carbohydrate-Restricted Diet with and without Supplemental Soluble Fiber on Plasma Low-Density Lipoprotein Cholesterol and Other Clinical Markers of Cardiovascular Risk.” Metabolism: Clinical and Experimental 56, no. 1 (January 1, 2007): 58–67. [PubMed]

Share this:

Like this: